Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 403

    Indian Pharma exports to USA may go up in 2017-18: Report

    Indian Pharma exports to USA may go up in 2017-18: Report

    Ruby Khatun Khatun19 July 2017 9:32 AM IST
    Hyderabad: Despite pricing pressure and stiff competition, the Indian Pharma exports to the USA may go up in 2017-18 as USD 50 billion worth of drugs...
    Amazing opportunities for start-ups in heatlh care: GV Prasad

    Amazing opportunities for start-ups in heatlh care: GV Prasad

    Ruby Khatun Khatun19 July 2017 9:30 AM IST
    Hyderabad: There are "amazing" growth opportunities for start-ups in the health care sector in India in terms of technology and patient-centric...
    Indian pharma firms need to increase research and development investment: Report

    Indian pharma firms need to increase research and development investment: Report

    Ruby Khatun Khatun18 July 2017 10:00 AM IST
    New Delhi: Indian pharma firms need to increase investments in research and development and quality of manufacturing to comply with global regulatory...
    Cipla looks out for marketing tie-up with Novartis

    Cipla looks out for marketing tie-up with Novartis

    Ruby Khatun Khatun18 July 2017 9:53 AM IST
    MUMBAI: Cipla, and Novartis are looking at the possibilities to jointly market asthma drug Xolair (omalizumab) an injectable prescription medicine...
    GST will benefit Ayurvedic industry in the long run: Kairali Ayurvedic Group

    GST will benefit Ayurvedic industry in the long run: Kairali Ayurvedic Group

    Ruby Khatun Khatun18 July 2017 9:53 AM IST
    New Delhi: Hailing the Goods and Services Tax (GST) imposed by the Centre from July 1, Executive Director Kairali Ayurvedic Group Abhilash K Ramesh...
    Janssen Wins FDA Approval of Tremfya (Guselkumab) for the treatment of Plaque Psoriasis

    Janssen Wins FDA Approval of Tremfya (Guselkumab) for the treatment of Plaque Psoriasis

    Ruby Khatun Khatun18 July 2017 9:53 AM IST
    Horsham, PA: Janssen Biotech, Inc. (Janssen) announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA™ (guselkumab) for the...
    Novartis stocks drug cabinet with Big-3 arthritis blockbusters

    Novartis stocks drug cabinet with Big-3 arthritis blockbusters

    Ruby Khatun Khatun17 July 2017 9:50 AM IST
    ZURICH: Switzerland's Novartis is stocking up cheaper versions of the world's top-selling arthritis medicines, hoping a broad portfolio gives it an...
    GV Prasad launches Cancer Clinics in Hyderabad

    GV Prasad launches Cancer Clinics in Hyderabad

    Ruby Khatun Khatun17 July 2017 9:45 AM IST
    Hyderabad: 'Cancer Clinics', a start-up venture for dedicated cancer treatment, was launched here Saturday.It offers screening, information, advice on...
    Zydus Cadila gets USFDA nod for sclerosis drug

    Zydus Cadila gets USFDA nod for sclerosis drug

    Ruby Khatun Khatun17 July 2017 9:40 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received tentative nod from the US health regulator to market Fingolimod capsules used for treatment of...
    Abbott, Bigfoot Biomedical Announce Collaboration to Develop Breakthrough Diabetes Technologies

    Abbott, Bigfoot Biomedical Announce Collaboration to Develop Breakthrough Diabetes Technologies

    Ruby Khatun Khatun17 July 2017 9:35 AM IST
    Abbott and Bigfoot Biomedical announced that the companies have entered into an agreement to develop and commercialize diabetes management systems,...
    Nutraceuticals market may grow to 10 billion dollar by 2022: Assocham

    Nutraceuticals market may grow to 10 billion dollar by 2022: Assocham

    Ruby Khatun Khatun17 July 2017 9:07 AM IST
    Mumbai: Indian nutraceuticals market is expected to grow at a compounded annual growth rate of 21 per cent and reach USD 10 billion by 2022 from USD 4...
    Stryker awarded 248.7 million dollar in patent case against Zimmer

    Stryker awarded 248.7 million dollar in patent case against Zimmer

    Ruby Khatun Khatun16 July 2017 10:03 AM IST
    A U.S. judge has increased the amount medical device maker Zimmer Biomet Holdings Inc must pay Stryker Corp for infringing patents on a surgical...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok